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Coronaviruses are positive-strand RNA viruses that replicate in the cytoplasm of infected cells by generating a membrane-associated replicase
complex. The replicase complex assembles on doublemembrane vesicles (DMVs). Here, we studied the role of a putative replicase anchor, nonstructural
protein 4 (nsp4), in the assembly of murine coronavirus DMVs. We used reverse genetics to generate infectious clone viruses (icv) with an alanine
substitution at nsp4 glycosylation siteN176 orN237, or an asparagine to threonine substitution (nsp4-N258T), which is proposed to confer a temperature
sensitive phenotype. We found that nsp4-N237A is lethal and nsp4-N258T generated a virus (designated Alb ts6 icv) that is temperature sensitive for
viral replication. Analysis of Alb ts6 icv-infected cells revealed that there was a dramatic reduction in DMVs and that both nsp4 and nsp3 partially
localized to mitochondria when cells were incubated at the non-permissive temperature. These results reveal a critical role of nsp4 in directing
coronavirus DMVassembly.
© 2008 Elsevier Inc. All rights reserved.Keywords: Coronavirus; Nonstructural proteins; Double membrane vesicles; ts mutantIntroduction
All positive-stranded RNA viruses that infect mammalian
and plant hosts form membrane-associated replication com-
plexes in the cytoplasm of infected cells (Salonen et al., 2005).
Coronaviruses, such as mouse hepatitis virus (MHV) and
severe acute respiratory syndrome coronavirus (SARS-CoV)
that causes severe respiratory illness in humans (Peiris et al.,
2004; Stadler et al., 2003), generate double membrane vesicles
(DMVs), which are the sites of viral RNA synthesis (Baker
and Denison, 2008; Goldsmith et al., 2004; Gosert et al., 2002;
Snijder et al., 2006). The DMVs are generated by the
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doi:10.1016/j.virol.2008.01.018host intracellular membranes (Gosert et al., 2002; Harcourt et
al., 2004; Prentice et al., 2004; Shi et al., 1999; Snijder et al.,
2006). However, the role of each of the coronavirus
nonstructural proteins in the assembly of DMVs is not yet
clear.
The coronavirus nonstructural proteins are translated from
the 5′-most gene of the genome, gene 1. Gene 1 contains two
open reading frames (ORFs) that produce two large poly-
proteins, pp1a and pp1ab (Fig. 1A). Polyprotein 1a is processed
by viral proteinases to generate intermediates and mature
products nsp1-nsp11. Polyprotein 1ab is generated by a
ribosomal frameshift between ORF1a and ORF1b and contains
all 16 nsps (Masters, 2006; Ziebuhr and Snijder, 2007). For
MHV, these large polyproteins undergo extensive proteolytic
processing by three virally encoded proteinases, papain-like
proteinase (PLP) 1, PLP2, and 3C-like proteinase (3CLpro) to
produce intermediate and mature replicase proteins (Baker et
al., 1989; Bonilla et al., 1997; Bost et al., 2000; Denison et al.,
1995; Graham and Denison, 2006; Kanjanahaluethai and
Fig. 1. MHV replicase highlighting predicted nsp4 topology and analysis of N-linked glycosylation. (A) The first two-thirds of the MHV genome (ORF 1a and ORF
1b) encode the viral replicase proteins. The nonstructural proteins (nsps) are synthesized as polyproteins processed into precursors then 16 mature replicase products.
(B) Analysis of p150 and nsp4 after tunicamycin and endo H treatments. HeLa-MHVR cells were infected with MHV-JHM, untreated (U) or treated with 1 µg/ml of
tunicamycin (T) for 1 h prior to and during labeling. Endo H treatment (E) was performed after immunoprecipitation with α-nsp4. (C) HeLa-MHVR cells were infected
with vTF7.3, and co-transfected with plasmids encoding PLP2 and substrate encoding either WT or mutant nsp4. Proteins were radiolabeled (35S-trans-label) and
immunoprecipitated with α-nsp4 antibodies. IP products were untreated or treated with endo H, separated on 5–10% gradient SDS-PAGE gel, and visualized by
autoradiography. (D) Predicted topology of nsp4 indicating the location of two glycosylation sites and a ts lesion within the luminal loop.
119M.A. Clementz et al. / Virology 375 (2008) 118–129Baker, 2001; Kanjanahaluethai et al., 2003; Lu et al., 1998,
1995; Schiller et al., 1998). The replicase intermediate p150
contains the mature products nsp4-nsp11 and has been
proposed to be functional in the synthesis of negative strand
RNA and/or as a scaffold for the assembly of the transcriptase/
replicase complex (Kanjanahaluethai and Baker, 2000; Sawicki
et al., 2007, 2005).
Bioinformatic analysis indicates that the replicase products
nsp3, nsp4, and nsp6 have membrane spanning helices (Ziebuhr
et al., 2000). Biochemical fractionation studies have shown that
nsp3 and nsp4 are integral membrane glycoproteins (Gosert et al.,
2002; Kanjanahaluethai et al., 2007; Oostra et al., 2007).
Recently, Sparks et al. (2007) showed that the amino terminal
region of nsp4 is essential for viral replication as deletions in this
region are lethal. Furthermore, Sawicki et al. (2005) sequenced a
large panel of temperature sensitive (ts) mutants of MHV and
identified one ts mutant, Alb ts6, that contained a substitution of
asparagine to threonine at amino acid position 258 within the
amino terminal region of nsp4. This mutation was predicted toconfer the RNAminus ts phenotype, but how thismutation affects
MHV RNA synthesis is not yet understood.
To investigate the role of specific asparagine residues within
the amino terminal domain of nsp4 in MHV replication, we
engineered amino acid substitutions at putative glycosylation sites
nsp4-N176 and nsp4-N237 and the putative ts lesion nsp4-N258
and isolated infectious clone virus (icv). We found that nsp4-
N176 and nsp4-N237 are glycosylated and that substitution of
nsp4-N237 to alanine was lethal for virus replication, whereas
substitution of nsp4-N176 to alanine had no effect on virus rep-
lication. Our results show that the asparagine to threonine
substitution at nsp4-258 was sufficient to bestow a ts phenotype,
and this virus was designated Alb ts6 icv. We found that pro-
teolytic processing of p150 is unaffected in theAlb ts6 icv at either
temperature. However, at the non-permissive temperature, DMV
assembly and mitochondria morphology are disrupted in Alb ts6
icv-infected cells and viral replicase proteins partially localize
with mitochondria. These data demonstrate that nsp4 is an
important factor in DMV assembly and are consistent with the
120 M.A. Clementz et al. / Virology 375 (2008) 118–129hypothesis that nsp4 is an anchor or scaffold for the replication
complex.
Results
MHV replicase precursor p150 and product nsp4 are modified
by N-linked glycosylation
Previous studies indicated that MHV nsp4 is a glycoprotein
(Oostra et al., 2007), but it was unclear if the p150 precursor was
also modified. To determine if both the precursor p150 and the
mature product nsp4 are modified by N-linked glycosylation, we
analyzed these proteins for sensitivity to tunicamycin and
endoglycosidase H (endo H). MHV-infected cells were
radiolabeled with 35S-trans-label and either mock-treated or
treated with tunicamycin and lysates and were subjected to
immunoprecipitation with anti-nsp4 and then treated with endo
H.We found that both the precursor p150 and the mature product
nsp4 were modified by N-linked glycosylation and that these
modifications were sensitive to endo H, indicating that these
proteins did not progress past the endoplasmic reticulum (ER)
(Fig. 1B).
Bioinformatic analysis indicated that nsp4 residues N176 and
N237 are consensus sites for N-linked glycosylation (consensus
sequence: NXS/T). To determine if nsp4-N176 and nsp4-N237
are specifically modified by N-linked glycosylation, a cDNA
clone [MHV-Cen-nsp4 (Kanjanahaluethai and Baker, 2000)]
expressing the entire nsp4 region and the cleavage site rec-
ognized by PLP2, was subjected to site-directed mutagenesisTable 1
Primers used for engineering icv mutants, RT-PCR, and sequencing
Primer Sequence (5′-3′)
A59-4 TCTTAATAGCGGCCAACACC
A59-18 CATGAATGGTCTGCTGCATT
A59-CS1 GTGGCAATGGCAAGAGG
A59-DS1 CATGTACAGGCTAATGTTG
A59-3 TGTTAACTTCCGCTCCTGCT
MAC-3 CTCGCTCTATGACCTACTGC
MAC-4 CAGTCCAGTTACGCTGGAGTC
MAC-5 AACTGCCCGACGATGTTG
MAC-6 TGTGGTGTTGGCTAGTGATG
MAC-7 GCTGCTGATGTCAAAGAGG
MAC-8 TGCCTGCTATTGTGCTGTG
MAC-9 CGTTTGTGGGACAGATAG
MAC-10 CATTGGAGTGCTCGTTTG
B-MUT AACCCATGCATTTGCTACTG
B285-JHM GGGTGTTATGCATGCTGCTTCTCTGTATAG
B286-JHM CTATACAGAGAAGCAGCATGCATAACACCC
B287-JHM ATTTGTTTTAATTTTGCTAGTTCATGGGTACTG
B288-JHM CAGTACCCATGAACTAGCAAAATTAAAACAAAT
B285-A59 GGGTGTTATGCACGCTGCCTCTCTGTATAG
B286-A59 CTATACAGAGAGGCAGCGTGCATAACACCC
B287-A59 ATCTGCTTTAATTTTGCTCGTTCATGGGTATTG
B288-A59 CAATACCCATGAACGAGCAAAATTAAAGCAGAT
MAC-1 GTGGTAGGACAGCTTTTGATTTAATACATC
MAC-2 CAAAAGCTGTCCTACCACAAAAAGTTCCAG
a Numbering according to MHV-A59 GenBank accession number NC001846 or M
indicate the mutated nucleotides.to generate alanine substitutions at these sites, and the mobility
of WT and mutant forms of nsp4 was assessed by SDS-PAGE.
Cells were transfected with constructs expressing pPLP2
(proteinase) and either WT or mutant forms of pCen-nsp4
DNA (substrate) and newly synthesized proteins were radi-
olabeled with 35S-trans-label. Cell lysates were prepared and
subjected to immunoprecipitation with an α-nsp4 antibody to
detect the mature form of nsp4 generated by cleavage of Cen-
nsp4 by PLP2. The immunoprecipitated nsp4 was either mock-
treated or endo H treated and electrophoretic mobility of protein
was assessed. As seen in Fig. 1C, nsp4 encoding either the
N176A or N237A substitutions exhibited faster migration as
compared to WT nsp4. The nsp4-N176A/N237A double mutant
migrated faster than either single mutant. For products treated
with endo H, which cleaves N-linked oligosaccharides, the
mobility of all four proteins was similar to that of the nsp4-
N176A/N237A double mutant, as expected. These data indicate
that nsp4-N176 and nsp4-N237 are in fact subjected to N-linked
glycosylation.
Recent studies have suggested that an asparagine residue
in the luminal domain of nsp4 is important for MHV RNA
synthesis. Sawicki et al. (2005) analyzed a series of MHV
temperature sensitive mutants that do not make viral RNA at the
non-permissive temperature. They identified one virus, desig-
nated as Alb ts6, with an asparagine to threonine substitution
at nsp4 residue 258. This residue was implicated as the site
responsible for temperature sensitive defect. However, the
mechanism by which this substitution in nsp4 causes the defect
in RNA synthesis in Alb ts6 is not known. A schematic diagramNucleotides a Sense Purpose
10991–11010 − RT-PCR
8003–8022 + RT-PCR/Sequencing Clone B
5411–5427 + Sequencing Clone B
8523–8541 + Sequencing Clone B
5066–5085 + Sequencing Clone B
9361–9380 + Sequencing Clone B
pSMART vector + Sequencing Clone B
5773–5790 + Sequencing Clone B
6224–6243 + Sequencing Clone B
6567–6585 + Sequencing Clone B
6887–6905 + Sequencing Clone B
7165–7182 + Sequencing Clone B
7518–7535 + Sequencing Clone B
9080–9099 + Sequencing Clone B
9247–9276 + nsp4-N176A pCen-nsp4
9247–9276 − nsp4-N176A pCen-nsp4
9428–9460 + nsp4-N237A pCen-nsp4
9428–9460 − nsp4-N237A pCen-nsp4
9233–9262 + nsp4-N176A Clone B
9233–9262 − nsp4-N176A Clone B
9414–9446 + nsp4-N237A Clone B
9414–9446 − nsp4-N237A Clone B
9484–9513 + nsp4-N258T Clone B
9472–9501 − nsp4-N258T Clone B
HV-JHM GenBank accession number NC006852. The underlined nucleotides
121M.A. Clementz et al. / Virology 375 (2008) 118–129of nsp4 topology indicating the position of the two asparagine
residues modified by N-linked glycosylation, and an asparagine
to threonine change predicted to be responsible for the
temperature sensitive phenotype are depicted in Fig. 1D.
Generating infectious clone viruses with amino acid
substitutions in nsp4
To determine if nsp4-N176, nsp4-N237, or nsp4-N258 is
important for nsp4 function, we generated virus encoding each
specific substitution. Each substitution was introduced into the
MHV-A59 genome using a reverse genetics approach pioneered
by Yount et al. (2002) as described in the Materials and
methods. Briefly, PCR based site-directed mutagenesis was
performed on the plasmid DNA containing the region of nsp4 to
be mutated (Clone B) using specific primers (Table 1). Each
mutant clone B DNA fragment was ligated with the remaining
six WT fragments to produce full-length MHV cDNA which
was then in vitro transcribed using T7 RNA polymerase.
Infectious RNAwas electroporated into BHK-MHVR cells and
cells were laid over a semi-confluent monolayer of DBT cells.
Cells were incubated at 33 °C and scored for cytopathic effect.
Supernatant from cells showing syncytia formation was
collected and passaged over a fresh monolayer of DBT cellsFig. 2. Sequence analysis of mutant infectious clone virus. DBTcells were infected
with WT-A59 icv, nsp4-N176A icv, or Alb ts6 icv and at 12 h.p.i. RNA was
isolated. RT-PCRwas performed on viral RNA using primers listed in Table 1, and
PCR products were sequenced across the nsp4 region.
Fig. 3. Growth characteristics of infectious clone viruses. (A) Titer ofWT-A59 icv,
Alb ts6 icv, and nsp4-N176A icv following infection at the permissive or
nonpermissive temperature for 15 hours, when supernatant was harvested and virus
titrated at 33 °C. Plaques were counted 48 h.p.i. Black bars, WT-A59 icv; white
bars, Alb ts6 icv; gray bars, nsp4-N176A icv. Viral titers were performed in
triplicate; error bars indicate standard deviation from the mean. (B) One-step
growth curve of WT-A59 icv, Alb ts6 icv, and nsp4-N176A icv at the permissive
temperature of 33 °C. Supernatant was collected at the indicated time points and
viral titer was determined by plaque assay.to generate a stock of infectious clone virus. RNAwas isolated
from mock and icv-infected DBT cells and RT-PCR was per-
formed to amplify the region containing the mutation of interest.
Amplicons were sequenced to verify the presence of the engi-
neered mutation (Fig. 2). Infectious viruses were successfully
obtained for position N176A (referred to as nsp4-N176A icv)
and N258T (designated Alb ts6 icv). However, we were unable
to generate the nsp4-N237A single or nsp4-N176A/N237A
double mutant virus, which indicates that mutation of N237
may be lethal for nsp4 function.
Analysis of the ts phenotype in nsp4-mutant MHV icv
To determine if either Alb ts6 icv or nsp4-N176A icv is
temperature sensitive, we measured the amount of infectious
particles produced by virus-infected cells incubated at the
permissive (33 °C) or non-permissive (39.5 °C) temperature and
titrated at the permissive temperature. Two sets of DBT cells
were infected with WT-A59 icv, Alb ts6 icv, or nsp4-N176A icv
at an MOI of 0.1. One set of infected cells was maintained at the
Fig. 4. Temperature shift assay on infectious clone virus. Two sets of DBT cells
were infected with WT-A59 icv, Alb ts6 icv, or nsp4-N176A icv at an MOI of
0.1 and incubated at 33 °C. At 6 h.p.i., one set of infected cells was shifted to
39.5 °C. Supernatant was harvested at two hour intervals and virus production
was measured by plaque assay. Arrow indicates time of temperature shift.
Fig. 5. Proteolytic processing of infectious clone virus. DBT cells were infected
with WT-A59 icv, Alb ts6 icv and nsp4-N176A icv, at 4 h.p.i. radiolabeled with
35S-trans-label for 2 h, and at 6 h.p.i. cell lysates were prepared and subjected to
immunoprecipitation with (A) α-nsp4, (B) α-nsp5, (C) α-nsp8, and (D) α-nsp9/
10. All replicase antibodies also detect the p150 precursor.
122 M.A. Clementz et al. / Virology 375 (2008) 118–129permissive temperature of 33 °C, while the other was incubated
at the non-permissive temperature of 39.5 °C. At 15 h.p.i., cell-
free supernatant was collected. Ten-fold serial dilutions (in
triplicate) of isolated supernatant were used to infect DBT cells
incubated at the permissive temperature. After 48 h, plaques
were counted and viral titer was determined. WT-A59 icv re-
plicated to high titers of 1.08×107 plaque forming units (PFU)/
ml at 33 °C and 1.42×107 PFU/ml at 39.5 °C. nsp4-N176A icv
also produced a similar size of plaques and reached titers of
1.33×107 PFU/ml at 33 °C and 1.75×107 PFU/ml at 39.5 °C.
The Alb ts6 icv replicated efficiently at 33 °C (1.08×107 PFU/
ml), but replication was dramatically reduced at 39.5 °C
(4.08×102 PFU/ml) (Fig. 3A). One-step growth curve analysis
was then performed on WT-A59 icv, Alb ts6 icv, and nsp4-
N176A icv. DBT cells were infected with icv at a multiplicity of
infection of 0.1, incubated at the permissive temperature, and
production of infectious virus was monitored by plaque assay.
As shown in Fig. 3B, when grown at 33 °C, WT-A59 icv, Alb
ts6 icv, and nsp4-N176A icv all replicated with indistinguish-
able kinetics.
Temperature shift experiments were then performed to further
assess the ts phenotype. Two sets of DBT cells were infected
with WT-A59 icv, Alb ts6 icv, or nsp4-N176A icv at an MOI of
0.1 and incubated at 33 °C. At 6 h.p.i., one set of infected cells
was shifted to 39.5 °C. Supernatant was harvested at two hour
intervals and virus production was measured by plaque assay. As
depicted in Fig. 4,WT-A59 icv, nsp4-N176A icv, and Alb ts6 icv
at 33 °C grew to similar titers and statistical analysis revealed
that all icvs exhibited a common growth curve ( p=0.9459). At
39.5 °C however, Alb ts6 icv titers fell over 3 logs by 12–14 h.p.
i. as compared to WT-A59 icv or nsp4-N176A icv, and Alb ts6
icv exhibited distinct growth kinetics ( pb0.0001). Taken
together, these data indicate that the N258T mutation in nsp4
is sufficient to confer a ts phenotype to the Alb ts6 icv.
Analysis of proteolytic processing of p150 in the Alb ts6 icv and
nsp4-N176A icv
One possible explanation for the ts phenotype of the Alb ts6
icv is that nsp4 processing is altered at the non-permissive
temperature. To address this issue, DBT cells were infected withWT-A59 icv, Alb ts6 icv, and nsp4-N176A icv at an MOI of 1.0
and at 4 h.p.i. radiolabeledwith 35S-trans-label for 2 h. At 6 h.p.i.,
cell lysates were prepared and subjected to immunoprecipitation
with nsp-specific antibodies. As seen in Figs. 5A–D, a large
precursor of 150 kDa is detected from which the mature nsp4-
nsp10/11 products are generated (Kanjanahaluethai and Baker,
2000). The liberation of nsp4 was detected in cells infected with
WT-A59 icv, Alb ts6 icv, or nsp4-N176A icv virus at both the
permissive and non-permissive temperature. Themobility of nsp4
in the nsp4-N176A icvwas increased,which is consistent with the
absence of glycosylation at amino acid 176 (Fig. 5A). The
processing of nsp5, nsp8, nsp9, and nsp10 was also unaffected in
cells infectedwithWT-A59 icv, Alb ts6 icv, or nsp4-N176A icv at
both temperatures (Figs. 5B–D). Overall, these results indicate
that the ts phenotype is not due to any alteration in the processing
of nsp4 or other p150-derived replicase products.
Ultra-structural analysis of DMVassembly in icv-infected cells
We hypothesize that nsp4 is a key anchor for DMVassembly
and therefore asked if the formation of DMVs was altered
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permissive temperature. We assessed DMV formation by
transmission electron microscopy (TEM) analysis to determine
if the reported defect in RNA synthesis is due to a defect
in DMV assembly. Two sets of DBT cells were infected with
WT-A59 icv or Alb ts6 icv at an MOI of 1.0 and incubated at
33 °C. At 3.5 h.p.i., one set of infected cells was shifted to
39.5 °C. At 5.5 h.p.i., cells were harvested and processed for
TEM analysis. DMVs can be visualized by TEM as darkly
ringed vesicles in the cytoplasm of MHV-infected cells (Gosert
et al., 2002). As shown in Fig. 6, DMV formation induced by
WT-A59 icv was similar at both permissive and non-permissive
temperatures. At 33 °C, the Alb ts6 icv induced DMV formation
comparable to WT-A59 icv; however, at the non-permissive
temperature of 39.5 °C, the Alb ts6 icv produced fewer DMVs.Fig. 6. TEM analysis of DMV formation by the WT-A59 icv and Alb ts6 icv at the pe
with WT-A59 icv or Alb ts6 icv at an MOI of 1.0 and incubated at 33 °C (A and C). At
cells were harvested and processed for TEM analysis. DMVs can be visualized by TE
the arrows. Asterisks denote mitochondria. Scale bar equals 1 μm.The most striking feature we observed was that the morpho-
logy of the mitochondria was altered in cells infected with
the Alb ts6 icv incubated at 39.5 °C. As seen in Fig. 6D, the
mitochondria were larger and extensively vacuolated. The
overall reduction in DMVs and the striking change in mito-
chondrial morphology lead us to hypothesize that the mutation
in nsp4 resulted in altered localization of nsp4 and potentially
other MHV replicase products, resulting in a block in viral RNA
synthesis.
Co-localization of MHV replicase proteins with mitochondria
The abnormalities observed in the mitochondria of cells
infected with Alb ts6 icv incubated at the non-permissive
temperature led us to explore whether MHV replicase proteins,rmissive and non-permissive temperatures. Two sets of DBT cells were infected
3.5 h.p.i., one set of infected cells (B and D) was shifted to 39.5 °C. At 5.5 h.p.i.,
M as darkly ringed vesicles in the cytoplasm of MHV-infected cells indicated by
Fig. 7. Localization of MHVreplicase proteins and a mitochondrial marker in DBTcells infected withWT-A59 icv and Alb ts6 icv. Two sets of DBTcells were infected
with WT-A59 icv or Alb ts6 icv at an MOI of 1.0 and incubated at 33 °C. At 3.5 h.p.i., one set of infected cells was shifted to 39.5 °C. At 5 h.p.i. cells were labeled with
MitoTracker Red fluorescent dye. At 5.5 h.p.i., cells were harvested, fixed, and permeabilized for immunofluorescence assays. Permeabilized cells were then incubated
with antibodies to either nsp4 (A) or nsp3 (B). Scale bar equals 10 μm.
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1999), were co-localizing with mitochondria. Two sets of DBT
cells were infected with WT-A59 icv or Alb ts6 icv at an MOI
of 1.0 and incubated at 33 °C. At 3.5 h.p.i., one set of infected
cells was shifted to 39.5 °C. At 5 h.p.i., cells were labeled with
MitoTracker Red fluorescent dye, which is concentrated by
active mitochondria. At 5.5 h.p.i., cells were harvested, fixed,
and permeabilized for immunofluorescence assays. Permeabi-
lized cells were then incubated with antibodies to either nsp3
or nsp4. As shown in Fig. 7A, staining for nsp4 (green) and
mitochondria (red) was non-overlapping in cells infected with
WT-A59 icv at either temperature. At the permissive tempera-
ture, Alb ts6 icv nsp4 and mitochondria displayed a very slight
increase in co-localization versus WT-A59 icv. At 39.5 °C
however, co-localization of nsp4 and mitochondria was
substantially increased. The intensity of the red signal was
also increased in cells infected with Alb ts6 icv at the non-
permissive temperature, which may reflect the increased in size
of the mitochondria that we observed by TEM. Similar results
were obtained in three independent experiments, with exten-
sive co-localization detected only in the Alb ts6 icv-infected
cells incubated at the non-permissive temperature.
To extend these findings, we performed similar experiments
using HeLa cells stably transfected with the MHV receptor(MHVR). Two sets of HeLa-MHVR cells were infected with
WT-A59 icv or Alb ts6 icv at an MOI of 1.0 and incubated
at 33 °C. At 3.5 h.p.i., one set of infected cells was shifted
to 39.5 °C. At 5 h.p.i., mitochondria were labeled with
MitoTracker Red fluorescent dye or following fixation with
an antibody to pyruvate dehydrogenase (PDH), which is a
mitochondrial matrix protein. Antibodies against nsp3 and nsp4
were again used to detect replicase products. As seen in Fig. 8,
extensive overlap between replicase proteins nsp3 and nsp4 and
mitochondria was detected only in the Alb ts6 icv-infected cells
incubated at the non-permissive temperature (39.5 °C). Similar
results were obtained with MitoTracker stained HeLa-MHVR
cells and MitoTracker and PDH were found to completely
overlap (data not shown). These results are consistent with the
TEM studies and reveal that the mutant form of nsp4 is partially
localized to mitochondria at the non-permissive temperature.
Furthermore, we also detected co-localization with mitochon-
dria using the α-nsp3 antibody in Alb ts6 icv-infected cells
incubated at 39.5 °C (Figs. 7B and 8B). Importantly, nsp3, and
perhaps other replicase products, are misdirected due to nsp4
mis-localization and are likely unable to efficiently assemble
into functional DMVs in the Alb ts6 icv-infected cells. This
inability to generate functional DMVs and/or replication com-
plexes would lead to an inability to synthesize viral RNA,
Fig. 8. MHV replicase protein localization in icv-infected HeLa-MHVR cells using antibodies to the mitochondrial protein pyruvate dehydrogenase (PDH). Two sets
of HELA-MHVR cells were infected with WT-A59 icv or Alb ts6 icv at an MOI of 1.0 and incubated at 33 °C. At 3.5 h.p.i., one set of infected cells was shifted to
39.5 °C. At 5.5 h.p.i., cells were harvested, fixed, and permeabilized for immunofluorescence assays. Permeabilized cells were then incubated with antibodies to PDH
and either nsp4 (A) or nsp3 (B). Scale bar equals 10 μm.
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2005).
Discussion
Positive-strand RNA viruses express viral replicase proteins
that must interact with host intracellular membranes to create an
environment for optimal viral RNA synthesis. Coronaviruses
express replicase proteins that assemble to generate DMVs in
the cytoplasm of infected cells (Goldsmith et al., 2004; Gosert
et al., 2002; Snijder et al., 2006). In this study, we investigated
the role of one coronavirus replicase product, nsp4, in MHV
replication. Because nsp4 is a transmembrane protein, we hypo-
thesize that nsp4 is critical for assembly of the replication
complex on DMVs. To test this hypothesis, we generated
viruses with specific amino acid substitutions in nsp4 and
assessed the effect of these substitutions on viral replication.
First, we investigated the role of two putative N-linked
glycosylation sites in MHV replication. Using endo H assays,
we found that both the nsp4-11 precursor (p150) and the nsp4
product are modified by N-linked glycosylation (Fig. 1B). We
engineered alanine substitutions (nsp4-N176A and nsp4-N237A)
into WT-A59 virus and found that nsp4-N176A icv behaved
identically toWT-A59 icv suggesting that glycosylation at this site
is not required for MHV replication. However, we were unable togenerate either nsp4-N237A icv or nsp4-N176A/N237A (double
glycosylation knockout) icv suggesting that glycosylation of nsp4-
N237A, or specific folding of nsp4 in this luminal domain, is
required for MHV replication.
Next, we investigated the role of nsp4-N258 in MHV rep-
lication. Sawicki et al. (2005) analyzed the sequence of 19MHV
ts mutants and reported that one of these mutant viruses, Alb ts6,
encoded a substitution of asparagine for threonine at nsp4-258.
They hypothesized that this mutation alone was sufficient to
confer the ts and RNA synthesis-negative phenotype to MHV-
A59. Via reverse genetics, we engineered the nsp4-N258T
mutation into MHVand designated this virus as Alb ts6 icv. We
found that the nsp4-N258T substitution was indeed sufficient to
induce temperature sensitivity. Alb ts6 icv titers were reduced
approximately 5 orders of magnitude when incubated at the non-
permissive temperature; however, Alb ts6 icv titers at 33 °Cwere
comparable to WT-A59 icv (Fig. 3A). Growth kinetics, assayed
by a one-step growth curve at the permissive temperature,
were indistinguishable between Alb ts6 icv and WT-A59 icv.
However, temperature shift experiments revealed that upon
incubation at the non-permissive temperature, Alb ts6 icv titers
fell 1000 fold (Fig. 4).
Using a similar reverse genetics approach, Donaldson et al.
(2007) found that a single amino acid substitution in nsp10
conferred temperature sensitivity to the icTS-LA6 virus. This
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activity as proteolytic processing of the replicase intermediate
p150 was defective in icTS-LA6-infected cells incubated at the
non-permissive temperature. In contrast, we found that Alb ts6
icv had no defects in proteolytic processing when virus-infected
cells were incubated at the non-permissive temperature (Fig. 5).
An alternative explanation for the RNA minus ts phenotype of
Alb ts6 is that a mutation in nsp4 affects assembly of DMVs. To
test this hypothesis, we performed TEM analysis of Alb ts6 icv-
infected cells. This analysis revealed that DMV assembly is
severely impaired in the Alb ts6 icv-infected cells incubated at
the non-permissive temperature (Fig. 6D). The failure to
assemble DMVs, which are necessary for viral RNA synthesis,
is consistent with the RNA minus phenotype observed by
Sawicki et al. (2005). Our results demonstrate that nsp4 plays a
critical role in the formation and/or maintenance of DMVs.
Also, TEM analysis of Alb ts6 icv-infected cells incubated
at the non-permissive temperature showed a disruption of
mitochondrial morphology; the mitochondria were enlarged and
extensively vacuolated (Fig. 6D). Using confocal microscopy,
we assessed whether nsp4-N258T was localized to the
mitochondria. We found that nsp4-N258T partially co-localized
with mitochondria in virus-infected cells incubated at the non-
permissive temperature (Figs. 7A and 8A). Interestingly, we
found that replicase product nsp3 also co-localized with
mitochondria, suggesting that nsp4-N258T may direct the
localization of other replicase components (Figs. 7B and 8B).
Currently, it is unclear if a replicase precursor or only the final
replicase products are directed to specific membrane sites or if
nsp4 is actually penetrating the mitochondrial membrane. Since
nsp4 is an integral membrane protein originally derived from the
ER, the co-localization detected may be due to membrane
reorganization. DMVs are likely diffusible in the cytoplasm and
perhaps nsp4-N258T is directing the localization of DMVs
to mitochondria where they are sequestered or fused with
mitochondrial membranes. Further experiments will be required
to address this important issue.
The aberrant mitochondrial morphology and partial co-
localization with nsp3 and nsp3 raises questions about the role
for mitochondria in MHV replication. Could nsp4-N258T be
localizing to mitochondria in error resulting in reduced DMV
assembly? Or is there a mitochondrial phase in MHV replication
whose progression is inhibited by the nsp4-N258T substitution?
Previous studies demonstrate that for some viruses, the replicase
complex can be directed to use different membrane sources for
efficient virus replication. For example, Flock house virus
(FHV) normally induces spherules within the outer membrane
of the mitochondria providing precedence for the use of mito-
chondrial membranes as the site of membrane-bound replication
complex assembly (Kopek et al., 2007; Miller and Ahlquist,
2002; Miller et al., 2001). To determine if mitochondrial mem-
branes were required for replication, Miller et al. (2003)
replaced the mitochondrial outer membrane targeting signal of
FHV protein-Awith that of an ER targeting signal and measured
viral replication. They found that the ER-targeted replication
complex functioned as efficiently, if not more efficiently, than
the normal mitochondria-targeted replication complex. There-fore, a specific source of membranes for replication complex
assembly is not required for FHV. For MHV, it is unclear if the
replication complex could be appropriately targeted to mito-
chondria, or if cytoplasmic DMVs are critical for MHV rep-
lication. In addition, it will be interesting to determine if WT
nsp4 or nsp4-N258T expressed in trans can direct MHV
replication complexes to specific membrane sites.
Complementation studies are useful for identifying products
which can act in trans to provide a functional protein for a
defective gene product. Complementation analyses have been
done with a large panel of ts mutants within the MHV replicase
and have provided insights into the functions of intermediate
and fully processed replicase proteins (Baric et al., 1990;
Donaldson et al., 2007; Fu and Baric, 1994; Sawicki et al.,
2005; Schaad et al., 1990; Siddell et al., 2001; Younker and
Sawicki, 1998). Interestingly, although MHV ORF1a encodes
eleven mature nsps, mutants within ORF1a do not complement
each other. There are at least two possible explanations for these
results: 1) a polyprotein precursor, such as p150, may function
itself, or function in cis and therefore cannot be complemented
by mature nsp products (Deming et al., 2007; Sawicki et al.,
2005); and 2) mutations in one nsp may affect the production,
function or localization of multiple products and therefore
cannot be complemented by a trans-acting factor. For example,
virus with a mutation in nsp10 (TS-LA6) crossed with a nsp4
mutant (Alb ts6) do not complement each other (Sawicki et al.,
2005). Donaldson et al. (2007) suggest that the icTS-LA6,
which exhibits a processing defect, fails to complement due to
the inability to generate mature forms of nsp4-nsp16. Thus,
a mutation in a single nsp (nsp10) affects the production of
several nsps (nsp4-nsp16). Likewise, the mutation analyzed in
this study, nsp4-N258T, which results in defects in DMV
assembly and localization, also affects the localization of other
nsps, such as nsp3. Therefore, like the icTS-LA6, the defect in
Alb ts6 icv induces an overarching defect in MHV replication.
These observations highlight the complex nature of coronavirus
replication complex assembly and maturation and indicate that
interplay among partially and fully processed replicase products
ultimately leads to competent replication complexes.
The results presented in this study indicate that nsp4 is a
key component in DMVassembly and are consistent with nsp4
serving as an anchor or scaffold for the replication complex.
Analysis of cis and trans-acting viral and host factors will
further elucidate the processes required for assembly of the
coronavirus transcription/replication complex.
Materials and methods
Virus and cell lines
WT-A59 icv, Alb ts6 icv and nsp4-N176A icv were generated
using the MHV-A59 reverse genetics system developed by
Yount et al. (2002). WT and mutagenized clone B plasmids
were transformed into chemically competent MDS (Scarab
Genomics) cells. The remaining clones were transformed into
chemically competent XL-1 blue cells. Competent cells were
heat shocked for 45 s at 42 °C and plated on Luria-Bertani (LB)
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colonies were picked and grown in selection media (LB+
antibiotic) overnight at 25 °C. Subcultures of WT and mutant
clone B were grown at 37 °C in 350 ml of LB+antibiotic until
culture density reached an O.D. of 0.8–1.0 at 590 nm. The
remaining clones were treated similarly, but grown at 25 °C.
Delayed brain tumor (DBT) and baby hamster kidney (BHK)
expressing the MHV receptor (BHK-MHVR) cells were incu-
bated at 37 °C in minimal essential medium, MEM, (Gibco)
containing 5% fetal calf serum (FCS), 10% tryptose phosphate
broth, 2% penicillin/streptomycin, and 2% L-glutamine. HeLa-
MHVR cells were propagated in DMEM (Gibco) containing
10% FCS, 0.001 M sodium N-2-hydroxyethylpiperazine-N′-2-
ethanesulfonic acid, pH 7.4, 1% penicillin/streptomycin and 1%
L-glutamine.
Generating infectious clone virus
The coronavirus reverse genetics system described by Yount
et al. (2002) was used to generate virus encoding a single amino
acid substitution compared to MHV-A59. Primers with two
nucleotide changes designed to generate amino acid substitu-
tions at nsp4 positions N176 and N237 to alanine, and N258 to
threonine were incorporated into the MHV B plasmid DNA via
PCR based site-directed mutagenesis (QuikChange Kit, Strata-
gene, primers listed in Table 1). Plasmid DNAs containing the
specific mutations of interest were isolated and sequenced across
the entire B region (sequencing primers shown in Table 1). The
B plasmid DNA region of interest was excised and ligated with
the MHVA, C, D, E, and F isolated DNA fragments to produce
full-length viral cDNA, which was in vitro transcribed using
mMessage mMachine T7 kit (Ambion) according to the
manufacturer's instructions. Infectious RNAwas electroporated
into 4×106 BHK-MHVR cells and laid over 1.5×106 DBTcells
in 60 mm dishes in duplicate. Cells were incubated at 33 °C for
24–72 h and monitored for the characteristic cytopathic effect
(CPE) of MHV, which is syncytia formation. Supernatant from
cultures with CPE was passaged over a fresh monolayer of
confluent DBTcells to generate a stock of icv. RNAwas isolated
from virus-infected cells and subjected to reverse transcriptase
(RT)-PCR using primers that flanked the region of interest. PCR
amplicons were sequenced to verify the presence of the mutation
in infectious clone virus RNA (Fig. 2).
Reverse transcriptase-PCR
The region of viral RNA containing the mutation of interest
was RT-PCR amplified using the ImProm-II RT System
(Promega) followedby theAdvantage cDNAPCRkit (Clonetech)
according to the manufacturer's instructions. Specific primers are
listed in Table 1.
Determination of nsp4 glycosylation
HeLa-MHVR cells were infected with a recombinant
vaccinia virus expressing the bacteriophage T7 polymerase
(vTF7.3) at a multiplicity of infection of 10 for 1 h. Then, cellswere co-transfected with pPLP2-Cen DNA and either pCen-
nsp4 wild type or pCen-nsp4 mutant DNA (N176A, N237A, or
N176A/N237A) using Lipofectamine (Gibco) according to the
manufacturer's instruction as previously described (Fuerst et al.,
1986; Kanjanahaluethai and Baker, 2000). Proteins were
radiolabeled with 50 μCi of 35S-trans-label from 4.5 to 9.5 h.
p.i. Cells were harvested and lysed with lysis buffer A containing
4% SDS, 3% DTT, 40% glycerol and 0.065 M Tris at pH 6.8.
Cell lysates were subjected to immunoprecipitation assays as
described previously (Schiller et al., 1998). Briefly, radiolabeled
cell lysates was diluted in RIPA buffer (0.5%TritonX-100, 0.1%
SDS, 300 mM NaCl, 4 mM EDTA and 50 mM Tris–HCl, pH
7.4) and immunoprecipitated with α-nsp4 rabbit antiserum and
protein-A sepharose beads (AmershamBiosciences, Piscataway,
NJ). For endoglycosidase H (endo H) treatment, protein-A
sepharose–antibody–antigen complexes were washed once in
RIPA buffer. The endo H treatment was performed according to
the manufacturer's instruction (Roche). Briefly, the complexes
were resuspended in 20 µl of 50 mM sodium phosphate buffer,
pH 6.0, and incubated in the presence and absence of a final
concentration of 1 U/μl of endo H for 16 h at 37 °C. The
complex-bound sepharose beads were pelleted by centrifuga-
tion. The products were eluted from the beads by incubating with
2× Laemmli sample buffer at 37 °C for 30 min. Protein products
were separated via electrophoresis on 5–10% gradient SDS-
PAGE gels and were visualized by autoradiography.
In tunicamycin treatment experiments, MHV-infected HeLa-
MHVR cells were treated with 1 µg/ml tunicamycin (Boeh-
ringer Mannheim) for 1 h prior to addition of 35S-trans-label,
and the drug was present during the 1 h labeling period. Whole
cell lysates were prepared and subjected to immunoprecipitation
as described above.
Kinetic analysis and temperature shift assays
Viral titer of the WT-A59 icv, Alb ts6 icv, and nsp4-N176A
icv was determined via plaque assay. Two sets of DBT cells
were infected with WT-A59 icv, Alb ts6 icv, or nsp4-N176A icv
at an MOI of 0.1. One set of infected cells was maintained at the
permissive temperature of 33 °C, while the other was incubated
at the non-permissive temperature of 39.5 °C. At 15 h.p.i. cell-
free supernatant was collected. Ten-fold serial dilutions (in
triplicate) of isolated supernatant were used to infect DBT cells
seeded to 70% confluency in 12 well plates. Following a 1 h
absorption period, a 1 ml mixture of 0.4% Noble agar (DIFCO,
Detroit, MI) and MEM with 1% FCS and 2% penicillin/
streptomycin was added to each well. Infection was maintained
for 48 h at the permissive temperature (33 °C) and plates were
stained with 0.1% crystal violet solution for 10 min at room
temperature to visualize and count plaques.
One-step growth curves were generated by infecting DBT
cells at an MOI of 0.1 in 6-well plates. Cells were washed three
times with phosphate-buffered saline (PBS) following a 1 h
absorption phase. Three milliliters of fresh medium were added
and cells were incubated at 33 °C. Aliquots of supernatants were
collected 2, 4, 6, 8, 10, and 24 h.p.i. and the viral titer was
determined by plaque assay in DBT cells maintained at 33 °C.
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two sets of DBT cells with WT-A59 icv, Alb ts6 icv, or nsp4-
N176A icv at an MOI of 0.1 and incubated at 33 °C. At 6 h.p.i.,
one set of infected cells was shifted to 39.5 °C. Supernatant
was harvested at two hour intervals from 2–14 h.p.i. and virus
production was measured by plaque assay in DBT cells main-
tained at 33 °C.
Statistical analysis of virus kinetics
The logarithm of the titer of each virus (Y) was analyzed using
nonlinear regression modeling and the SAS® software package.
Since these data clearly exhibit an asymptotic growth pattern, the
two-parameter exponential model, Y=θ1(1−exp{−θ2x})+ε,
was fit to the data using 6 h post infection as the baseline.
Separate curves were fitted to each virus and temperature com-
bination; parameter estimates were obtained using maximum
likelihood methods, and subsequent tests were performed using
likelihood-based F tests (Ratkowsky, 1990).
Immunoprecipitation of cleavage products
Two sets of DBT cells were infected with WT-A59 icv, Alb
ts6 icv and nsp4-N176A icv at an MOI of 1.0 and incubated at
33 °C. One hour post infection, actinomycin D (Sigma, St.
Louis, MO) was added. At 3.5 h.p.i., cells were grown in media
lacking methionine for 30 min. Cells were radiolabeled with
35S-trans-label for 2 h at 4 h.p.i. At 4 h.p.i., one set of infected
cells was shifted to 39.5 °C. Cell lysates were prepared 6 h.p.i.
and subjected to immunoprecipitation with nsp-specific anti-
bodies as described above.
Transmission electron microscopy analysis of DMVs
Two sets of DBTcells were infected with WT-A59 icv or Alb
ts6 icv at anMOI of 1.0 and incubated at 33 °C. At 3.5 h.p.i., one
set of infected cells was shifted to 39.5 °C. At 5.5 h.p.i., cells
were harvested and processed for TEM analysis as previously
described (Gosert et al., 2002).
Confocal microscopy
Two sets of DBT or HeLa-MHVR cells were grown to semi-
confluence in 8well chamber slides coated with permanox. Cells
were infected with WT-A59 icv or Alb ts6 icv at an MOI of 1.0
and incubated at 33 °C for a 1 h absorption period. At 3.5 h.p.i.,
one set of infected cells was shifted to 39.5 °C. At 5 h.p.i., cells
were labeled with 65 nM MitoTracker Red fluorescent dye
(Invitrogen). At 5.5 h.p.i., cells were washed 3 times with PBS
and fixed for 30 min at room temperature with 3.7% formal-
dehyde in PBS. Cells were then permeabilized for 10 min at
room temperature with 0.1% Triton X-100 in PBS. Following
permeabilization, cells were incubated with either α-nsp3 or α-
nsp4 and/orα-PDH antibodies overnight at 4 °C. Cells were then
washed 3 times for 30 min in PBS. After washing, cells were
incubated with AlexaFluor 488 conjugated chicken α-rabbit
IgG (Invitrogen) and/or Alexa Fluor 568 goat α-mouse IgG(Invitrogen) secondary antibody for 30min at room temperature.
Cells were again washed 3 times for 30 min in PBS. Cells were
imaged on the Zeiss 510 confocal microscope.
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